Yuichiro Yamamoto
Tokyo, 1258585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry.
Journal: Journal of molecular biology
Published: February 11, 2026
Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance.
Journal: Biomolecules
Published: September 08, 2025
The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination.
Journal: International immunology
Published: June 23, 2025
Predictors of chemotherapy-related unplanned acute care in outpatients receiving oral anticancer drugs.
Journal: Scientific reports
Published: March 21, 2025
Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2.
Journal: Scientific reports
Published: March 21, 2025
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2.
Journal: Biological & pharmaceutical bulletin
Published: May 01, 2024
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid.
Journal: International journal of molecular sciences
Published: November 09, 2022
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing.
Journal: International journal of molecular sciences
Published: October 08, 2022
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione.
Journal: Biochemical and biophysical research communications
Published: January 18, 2022
Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs.
Journal: Anticancer research
Published: August 23, 2021
Last Updated: 09/26/2026